Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SLNO | SOLENO THERAPEUTICS INC | $52.94 | $40.09 | 32.06% | 132.35x | 13.15x | 14.13x | 6.07x | 0.48x | $46.73M | 1.74% | $450.12M | 8.86 | $2.72B | 93.67 | ||
| GYRE | GYRE THERAPEUTICS INC | $8.04 | $4.33 | 85.52% | 134.00x | -24.63x | 6.16x | 7.35x | 0.69x | -$150.00k | -0.02% | $106.03M | 1.19 | $743.46M | 57.90 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $11.25 | $18.24 | -38.31% | 8.04x | 22.69x | 5.84x | 4.27x | 0.36x | -$1.99M | -0.32% | $154.66M | 2.80 | $661.31M | 6.66 | ||
| ADMA | ADMA BIOLOGICS INC | $10.08 | $11.64 | -13.42% | 16.26x | 10.15x | 4.71x | 5.03x | 0.42x | $27.82M | 1.16% | $477.32M | 2.00 | $2.39B | 12.06 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $303.00 | $98.94 | 206.24% | 69.50x | 42.73x | 9.39x | 37.62x | 1.38x | $641.34M | 1.59% | $1.08B | 8.09 | $41.71B | 45.12 | ||
| CORT | CORCEPT THERAPEUTICS INC | $52.15 | $16.25 | 220.91% | 113.37x | 96.11x | 7.08x | 8.78x | 1.30x | $119.79M | 2.20% | $637.99M | 6.11 | $5.50B | -800.94 | ||
| KRYS | KRYSTAL BIOTECH INC | $288.99 | $102.91 | 180.83% | 37.29x | 36.76x | 20.28x | 6.67x | 1.62x | $237.38M | 2.80% | $1.28B | 43.59 | $8.03B | 37.52 | ||
| HALO | HALOZYME THERAPEUTICS INC | $66.35 | $69.65 | -4.74% | 25.13x | 8.04x | 5.69x | 160.41x | 0.41x | $644.59M | 8.11% | $48.81M | 0.41 | $9.84B | 17.17 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $4.97 | $3.04 | 63.48% | 20.71x | 18.21x | 3.05x | 4.81x | 0.98x | $4.11M | 1.03% | $82.33M | 1.03 | $331.86M | 15.62 | ||
| VCEL | VERICEL CORP | $36.78 | $8.26 | 345.21% | 111.45x | 82.89x | 6.70x | 5.26x | 1.95x | $24.75M | 1.34% | $354.64M | 7.05 | $1.86B | 53.39 | ||
| RPRX | ROYALTY PHARMA PLC | $50.72 | $42.36 | 19.72% | 26.55x | 9.59x | 9.08x | 2.94x | 0.54x | $2.34B | 10.57% | $9.94B | 22.75 | $37.58B | 32.30 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $54.60 | $41.92 | 30.25% | 39.00x | 12.08x | 3.24x | 1.70x | 0.55x | $767.06M | 7.30% | $6.21B | 32.27 | $8.91B | 18.47 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $228.57 | $49.41 | 362.60% | 486.32x | 9.39x | 3.19x | 3.16x | 1.68x | $1.30B | 9.17% | $4.53B | 73.22 | $17.90B | 26.52 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $58.23 | $16.25 | 258.25% | 59.42x | 52.79x | 5.91x | 7.40x | 1.82x | $164.23M | 3.69% | $605.69M | 7.92 | $4.30B | 38.56 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $232.55 | $85.26 | 172.74% | 36.11x | 25.21x | 16.77x | 4.56x | 1.58x | $48.09M | 1.07% | $1.02B | 52.60 | $4.91B | 24.64 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $32.78 | $35.66 | -8.07% | 11.88x | 9.18x | 2.17x | 2.18x | 0.54x | $347.89M | 18.46% | $870.22M | 15.14 | $1.31B | 5.13 | ||
| APLS | APELLIS PHARMACEUTICALS INC | $41.12 | $4.92 | 735.58% | 228.44x | -34.85x | 5.17x | 14.20x | 3.58x | $45.01M | 0.87% | $370.15M | 2.93 | $5.26B | 75.19 | ||
| TECH | BIO-TECHNE CORP | $47.41 | $15.21 | 211.74% | 91.16x | 23.44x | 6.08x | 3.69x | 1.31x | $223.02M | 3.02% | $2.01B | 12.90 | $7.59B | 33.54 | ||
| MNKD | MANNKIND CORP | $3.56 | $0.76 | 370.74% | 178.00x | -523.53x | 3.12x | -21.50x | 1.89x | $13.69M | 1.26% | -$51.02M | -0.17 | $1.63B | 30.74 | ||
| SPRO | SPERO THERAPEUTICS INC | $2.53 | $4.90 | -48.41% | 16.87x | 3.70x | 2.12x | 2.48x | 0.21x | -$12.62M | -8.89% | $59.02M | 1.05 | $109.10M | 12.35 | ||
| EXEL | EXELIXIS INC | $48.70 | $31.51 | 54.57% | 15.61x | 15.52x | 5.30x | 6.32x | 1.14x | $917.69M | 7.29% | $1.94B | 7.49 | $12.18B | 11.54 | ||
| UTHR | UNITED THERAPEUTICS CORP | $596.76 | $266.41 | 124.00% | 20.38x | 20.24x | 8.19x | 4.29x | 1.89x | $1.02B | 3.92% | $5.90B | 135.66 | $24.05B | 14.04 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $427.65 | $177.70 | 140.65% | 25.14x | 21.96x | 8.89x | 5.61x | 1.71x | $3.71B | 3.41% | $19.36B | 76.20 | $105.03B | 19.47 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $30.52 | $14.84 | 105.61% | 17.44x | 14.78x | 6.34x | 3.91x | 1.94x | $208.61M | 5.59% | $954.27M | 7.80 | $3.02B | 9.39 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $721.05 | $439.17 | 64.19% | 16.94x | 15.30x | 5.03x | 2.41x | 1.18x | $4.11B | 5.48% | $31.42B | 302.15 | $75.34B | 13.11 | ||
| MDXG | MIMEDX GROUP INC | $3.66 | $1.80 | 103.08% | 17.43x | -269.12x | 1.40x | 2.24x | 1.87x | $69.36M | 12.76% | $242.94M | 1.64 | $402.96M | 7.40 | ||
| SRPT | SAREPTA THERAPEUTICS INC | $23.03 | $6.86 | 235.60% | 38.38x | 7.23x | 1.11x | 1.62x | 2.18x | $109.24M | 4.52% | $1.51B | 14.34 | $3.00B | 36.31 | ||
| VCYT | VERACYTE INC | $41.19 | $9.91 | 315.66% | 49.04x | 45.04x | 6.26x | 2.50x | 2.63x | $126.63M | 3.91% | $1.31B | 16.67 | $2.95B | 31.84 | ||
| INCY | INCYTE CORP | $99.85 | $68.08 | 46.66% | 13.70x | 12.74x | 3.71x | 3.55x | 1.19x | $1.45B | 7.29% | $5.62B | 28.21 | $16.52B | 8.83 | ||
| PBYI | PUMA BIOTECHNOLOGY INC | $7.45 | $3.82 | 94.93% | 12.02x | 18.26x | 1.63x | 2.91x | 5.32x | $41.73M | 11.19% | $130.34M | 2.61 | $375.85M | 7.05 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.